Michael Tolentino was named Chief Executive Officer of Black Hawk Acquisition Corp. As of November 14, 2026, Black Hawk Acquisition Corp has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from February 3, 2026 to March 17, 2026, naming 3 appointments (Form 8-K, March 17, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Black Hawk Acquisition Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Black Hawk Acquisition Corp reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-03 to 2026-03-17. They name 3 people. Every row below is cited to the filing it comes from, and this page adds each new change as Black Hawk Acquisition Corp files it.
Also on the record for Black Hawk Acquisition Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 12, 2026 | Stake report, Schedule 13G/A, by Mizuho Financial Group, Inc. | — | 5%+ stakes | Source |
| November 9, 2026 | Stake report, Schedule 13G/A, by W. R. Berkley Corporation | 7.8% of the class | 5%+ stakes | Source |
| November 5, 2026 | Stake report, Schedule 13G/A, by Wolverine Asset Management, LLC | — | 5%+ stakes | Source |
| October 7, 2026 | Stake report, Schedule 13G/A, by Wolverine Asset Management, LLC | 5.09% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by First Trust Merger Arbitrage Fund | — | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Kerry Propper | 5.8% of the class | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G/A, by AQR Capital Management, LLC | 3.36% of the class | 5%+ stakes | Source |
| November 10, 2025 | Stake report, Schedule 13G/A, by W. R. Berkley Corporation | 7.4% of the class | 5%+ stakes | Source |
| October 10, 2025 | Stake report, Schedule 13G, by WOLVERINE ASSET MANAGEMENT LLC | 8.64% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G/A, by Mizuho Financial Group, Inc. | 8.4% of the class | 5%+ stakes | Source |
| August 8, 2025 | Stake report, Schedule 13G, by W. R. Berkley Corporation | 5.2% of the class | 5%+ stakes | Source |
| August 7, 2025 | Stake report, Schedule 13G/A, by KARPUS MANAGEMENT, INC. | — | 5%+ stakes | Source |
Selling to them or working with them? See who runs Black Hawk Acquisition Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on Black Hawk Acquisition Corp and the records around it.
Black Hawk Acquisition Corp elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Kerry Propper also filed stake reports on 5 other companies: Cayson Acquisition Corp. (May 2026), Future Vision II Acquisition Corp. (May 2026), Rising Dragon Acquisition Corp. (May 2026)
- First Trust Merger Arbitrage Fund also filed stake reports on 50 other companies: Audax Private Credit Fund, LLC (Nov 2026), Invesco Real Estate Income Trust Inc. (Nov 2026), Launch One Acquisition Corp. (Nov 2026)
- Wolverine Asset Management, LLC also filed stake reports on 75 other companies: AmperCap Acquisition Company (Oct 2026), BTC Development Corp. (Oct 2026), D. Boral Acquisition I Corp. (Oct 2026)
Watch Black Hawk Acquisition Corp
Get an email when Black Hawk Acquisition Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Black Hawk Acquisition Corp?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Black Hawk Acquisition Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Black Hawk Acquisition Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-17 | In | Chief Executive Officer | 8-K, 2026-03-17 | ||
| 2026-02-03 | In | Chief Financial Officer | 8-K, 2026-02-03 | ||
| 2026-02-03 | In | Director | 8-K, 2026-02-03 |
Who leads Black Hawk Acquisition Corp, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Michael Tolentino, appointed (filed 2026-03-17).
- Director: Frederick Woodruff Field, appointed (filed 2026-02-03).
- Chief Financial Officer: Mitchell Creem, appointed (filed 2026-02-03).
New leaders reset buying decisions — get the Full Report on Black Hawk Acquisition Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Black Hawk Acquisition Corp, with the record behind each one.
Find candidates like Chief Executive Officer at Black Hawk Acquisition CorpEvery change, in the filing's words
Appointed: Michael Tolentino, Chief Executive Officer
On March 17, 2026, Black Hawk Acquisition Corporation (the "Company") was advised that Michael Tolentino has been appointed as Chief Executive Officer ("CEO") of Vesicor Therapeutics, Inc. ("Vesicor"), the Company's proposed business combination target.
- Dr. Tolentino's appointment as CEO was effective as of March 17, 2026, which is the date that Vesicor and Dr. Tolentino signed an Employment Agreement for his services as CEO of Vesicor ("Agreement").
- Luo Feng, the former chief executive officer of Vesicor, has assumed the position of Chief Scientific Officer of Vesicor, effective March 17, 2026.
- The Agreement between Vesicor and Dr. Tolentino (referred to as the "CEO" in this paragraph) provides, in part, for: (1) Term.
- The initial term of the Agreement is 3 years from March 17, 2026 ("Term").
- The Term renews annually after the expiration of the initial 3 years, unless terminated by Vesicor or the CEO at least 90 days prior to the expiration of the initial 3-year term or a one-year renewal period; (2) Base Salary.
- The base salary is $48,000, which is subject to a mutually acceptable revised amount if Vesicor raises a minimum of $5 million; (3) Annual Bonus.
- The Agreement provides for an ad hoc annual bonus at the discretion of Vesicor's Board of Directors; (4) Termination.
Appointed: Mitchell Creem, Chief Financial Officer
Also on January 27, 2026, the board of directors of Vesicor (the "Vesicor Board") appointed Mitchell Creem to serve as Chief Financial Officer of Vesicor, effective immediately, to fill the vacancy created by Mr. Bowen's death.
Appointed: Frederick Woodruff Field, Director
On January 26, 2026, the Vesicor Board appointed Frederick Woodruff Field to serve as a member of its board of directors, effective immediately.
- On January 27, 2026, Black Hawk Acquisition Corporation (the "Company") reported that Michael Bowen, the Chief Financial Officer of Vesicor Therapeutics, Inc. ("Vesicor"), the Company's proposed business combination target, passed away.
- There is no employment agreement between Vesicor and Mr. Creem.
- The Vesicor Board has determined that Mr. Field satisfies the applicable "independent director" requirements under the rules of The Nasdaq Stock Market.
- Mitchell Creem Mr. Creem currently serves as the Chief Executive Officer and a director of Pioneer Acquisition Corporation (Nasdaq: PACH).
- He has over 35 years of experience as a senior executive in healthcare organizations.
- Mr. Creem served as a director of Nutex Health, Inc. (Nasdaq: NUTX) from April 2022 to July 14, 2025 and as a director of Clinigence Holdings, Inc. from April 2019 until April 2022.
- He is currently a principal at GreenRock Capital and has served as President of The Bridgewater Healthcare Group since July 2017.
- From October 2015 to July 2017, he served as Chief Executive and Administrative Officer of Verity Health Systems of California, Inc. Previously, Mr. Creem served in various roles at ApolloMed, now Astrana Health, Inc. (Nasdaq: ASTH), including Chief Financial Officer and director, and served as Chief Executive Officer of the Keck Hospital of USC and the USC Norris Cancer Center.
Tools for this story
Each opens in a new tab, filled in for Black Hawk Acquisition Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
